Century Therapeutics, Inc. (IPSC)
2.06
-0.08
(-3.74%)
USD |
NASDAQ |
Feb 20, 16:00
2.065
0.00 (0.00%)
Pre-Market: 20:00
Century Therapeutics EPS Diluted (Quarterly) : -0.3981 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Coherus Oncology, Inc. | -0.3021 |
| ALX Oncology Holdings, Inc. | -0.4133 |
| Climb Bio, Inc. | -0.1895 |
| PepGen Inc. | -0.5246 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.42M |
| Total Expenses (Quarterly) | 34.42M |
| Enterprise Value | 92.06M |
| Earnings Yield | -15.09% |
| Normalized Earnings Yield | -10.65 |